TOP TEN perturbations for 1514_g_at (Homo sapiens)

Organism: Homo sapiens
Gene: 1514_g_at
Selected probe(set): 204583_x_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 1514_g_at (204583_x_at) across 6622 perturbations tested by GENEVESTIGATOR:

prostate cancer study 8 (p. canc) / prostate cancer study 8 (ptasc)

Relative Expression (log2-ratio):6.769144
Number of Samples:3 / 2
Experimental prostate cancer study 8 (p. canc)
CD26+ FACS sorted prostate neoplasm cell (p. canc) samples from patients with primary prostate cancer collected after radical prostatectomy.
Control prostate cancer study 8 (ptasc)
CD90+ FACS sorted prostate tumor-associated stromal cell (ptasc) samples from patients with primary prostate cancer collected after radical prostatectomy.

prostate cancer study 8 (p. canc) / prostate cancer study 8 (psfmc)

Relative Expression (log2-ratio):3.5563889
Number of Samples:3 / 5
Experimental prostate cancer study 8 (p. canc)
CD26+ FACS sorted prostate neoplasm cell (p. canc) samples from patients with primary prostate cancer collected after radical prostatectomy.
Control prostate cancer study 8 (psfmc)
CD49a+ FACS sorted prostate stromal fibromuscular cell (psfmc) samples from patients with primary prostate cancer collected after radical prostatectomy.

prostate cancer study 6 (stroma) / noncancerous prostate stroma tissue

Relative Expression (log2-ratio):3.5108728
Number of Samples:6 / 6
Experimental prostate cancer study 6 (stroma)
Cancerous prostate stroma tissue from male patients associated to primary prostate carcinoma with stromal invasion, Gleason score 7 or higher and no lymph node metastasis (pN0).
Control noncancerous prostate stroma tissue
Noncancerous (normal) tissue cell samples after laser-microdissection from male patients with primary prostate carcinoma with stromal invasion, Gleason score 7 or higher and no lymph node metastasis (pN0).

prostate cancer study 1 (meta.) / prostate cancer study 1 (prim.)

Relative Expression (log2-ratio):-3.0091734
Number of Samples:6 / 7
Experimental prostate cancer study 1 (meta.)
Metastatic prostate cancer samples.
Control prostate cancer study 1 (prim.)
Primary prostate cancer samples.

dihydrotestosterone study 1 / untreated LNCaP cell sample

Relative Expression (log2-ratio):2.1997004
Number of Samples:3 / 2
Experimental dihydrotestosterone study 1
Human prostate carcinoma LNCaP cells stimulated with dihydrotestosterone (DHT; INN: androstanolone; 1nM; 16h). ATC code:
Control untreated LNCaP cell sample
Untreated human prostate carcinoma LNCaP cells not stimulated with dihydrotestosterone (DHT).

dihydrotestosterone study 2 (late) / untreated LNCaP cell sample

Relative Expression (log2-ratio):1.9627256
Number of Samples:3 / 3
Experimental dihydrotestosterone study 2 (late)
LNCaP prostate cancer epithelial cells treated with steroid hormone dihydrotestosterone (DHT; INN: androstanolone) for 16h. ATC code:
Control untreated LNCaP cell sample
Untreated LNCaP prostate cancer epithelial cells.

influenza virus study 11 (A/H5N3) / influenza virus study 4 (A/H1N1)

Relative Expression (log2-ratio):-1.7144022
Number of Samples:3 / 3
Experimental influenza virus study 11 (A/H5N3)
Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F119/3/1997(H5N3). Samples were taken 10 hours post-infection.
Control influenza virus study 4 (A/H1N1)
Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection.

renal cell carcinoma study 6 (chromophobe type) / normal kidney tissue

Relative Expression (log2-ratio):1.7068958
Number of Samples:4 / 2
Experimental renal cell carcinoma study 6 (chromophobe type)
Tumor tissue samples from the kidney of patients with chromophobe renal cell carcinoma (cRCC).
Control normal kidney tissue
Normal fetal kidney tissue samples.

prostate cancer study 7 ( met. crpc) / prostate cancer study 7 ( met. pca)

Relative Expression (log2-ratio):-1.6965446
Number of Samples:2 / 3
Experimental prostate cancer study 7 ( met. crpc)
Metastatic lymph node tissue sample of male patients with androgen-independent carcinoma of the prostate (castration-resistant prostate carcinoma) with prior therapy.
Control prostate cancer study 7 ( met. pca)
Metastatic lymph node tissue sample of male patients with primary prostate carcinoma with no prior therapy.

influenza virus study 10 (A/H5N2) / influenza virus study 4 (A/H1N1)

Relative Expression (log2-ratio):-1.6877346
Number of Samples:3 / 3
Experimental influenza virus study 10 (A/H5N2)
Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F189/07/2004(H5N2). Samples were taken 10 hours post-infection.
Control influenza virus study 4 (A/H1N1)
Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection.